Updated Jul 16, 2026
Furney Natalie Anne Marie has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Natalie Anne Marie Furney is a corporate legal executive who serves as Global General Counsel of Takeda Pharmaceutical Co Ltd, according to the most recent SEC filing dated 2026-07-06. In this role, Furney is responsible for Takeda's global legal strategy, regulatory compliance, corporate governance, intellectual property, litigation oversight, and coordinating with Takeda's board and senior management on risk and strategic initiatives. Her appointment places her among Takeda's senior leadership, making her a key participant in decisions affecting the multinational pharmaceutical company's operations and growth.
| Role | Global General Counsel |
|---|---|
| Notability | 65/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 43.9K | $0.00 |
Natalie Anne Marie Furney is a corporate legal executive who serves as Global General Counsel of Takeda Pharmaceutical Co Ltd, according to the most recent SEC filing dated 2026-07-06. In this role, Furney is responsible for Takeda's global legal strategy, regulatory compliance, corporate governance, intellectual property, litigation oversight, and coordinating with Takeda's bo…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Furney Natalie Anne Marie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.